Twist Bioscience Corporation
TWST
$119.18
-$6.11-4.88%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 20.38% | -44.30% | -12.41% | -233.09% | 151.85% |
| Total Depreciation and Amortization | 4.25% | 5.43% | 50.97% | -32.28% | -7.08% |
| Total Amortization of Deferred Charges | 50.00% | -33.33% | -85.71% | 600.00% | 50.00% |
| Total Other Non-Cash Items | -0.55% | 42.52% | -20.65% | 151.53% | -249.53% |
| Change in Net Operating Assets | 586.40% | 111.98% | -92.44% | -284.59% | 409.83% |
| Cash from Operations | 106.35% | 29.24% | -110.04% | -743.86% | 89.22% |
| Capital Expenditure | -23.79% | 20.92% | 19.74% | -35.59% | -121.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00% | -- |
| Other Investing Activities | 90.97% | -11,853.66% | 70.83% | 100.88% | -200.52% |
| Cash from Investing | 19.74% | -27.92% | 19.91% | -31.99% | -558.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -8.51% | 1,282.00% | -94.62% | 204.87% | -42.86% |
| Repurchase of Common Stock | 25.00% | -300.00% | 0.00% | 33.33% | 40.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.48% | 1,288.59% | -94.65% | 205.26% | -42.87% |
| Foreign Exchange rate Adjustments | 266.67% | -166.67% | -94.48% | 329.58% | -168.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.77% | 24.12% | -86.36% | -104.38% | 18.63% |